Image Ben Hargreaves Oncology Words matter: The power of language in cancer discussions The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible. Oncology Why is pharma going gaga for radiopharmaceuticals? The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage. Patients Patient feedback is creating next-gen drug delivery devices The patient voice has grown in importance, and now it is being applied to develop and deliver more sophisticated drug delivery devices. R&D The innovative future of CRISPR tech CRISPR-based therapies have moved from theory to reality, after the recent landmark approval of the first such treatment by the FDA. Load more results
Oncology Words matter: The power of language in cancer discussions The priority for any individual diagnosed with cancer is to be provided an effective therapy as quickly as possible.
Oncology Why is pharma going gaga for radiopharmaceuticals? The pharma industry is always on the lookout for new therapeutic angles that might prove to be a competitive advantage.
Patients Patient feedback is creating next-gen drug delivery devices The patient voice has grown in importance, and now it is being applied to develop and deliver more sophisticated drug delivery devices.
R&D The innovative future of CRISPR tech CRISPR-based therapies have moved from theory to reality, after the recent landmark approval of the first such treatment by the FDA.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
